Global Consensus Position Statement on the Use of Testosterone Therapy for Women
The Global Consensus Position Statement on the Use of Testosterone Therapy for Women was simultaneously published on the 2nd September 2019 in Maturitas, Journal of Clinical Endocrinolgy and Metabolism (JCEM), Climacteric and the Journal of Sexual Medicine in 14 languages.
Read the full paper at https://www.imsociety.org/position_papers_and_consensus_statements.php
Latest News
In Australia, is Addyi (Flibanserin) available or what is available?
Australia Leads the Way in Androgen Treatment for Women with HSDD While the US-approved drug flibanserin offers limited benefit for Hypoactive Sexual Desire Disorder (HSDD), it’s… Continue Reading →
How Satisfied are you with Your Sex Life?
Let’s Talk About Sexual Satisfaction—It Matters More Than You Think Did you know that 4 in 10 women experience sexual concerns during mid-life? Yet many suffer… Continue Reading →
MHRA approves testosterone cream for UK postmenopausal women
MHRA approves testosterone cream for UK postmenopausal women 12 August 2025 Perth, Australia and Guildford, England: Lawley Pharmaceuticals and its commercial… Continue Reading →